
|Videos|July 21, 2023
The Future of Research in PEComas
The panel shares future areas of research in malignant PEComa that interest them, and how they see the treatment landscape evolving.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Poll Results Reveal Readers’ Top Abstracts at ASH 2025
2
FDA Approves Liso-Cel as First CAR T-Cell Therapy for Marginal Zone Lymphoma
3
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
4
Lurbinectedin Contributes to Maintenance of Response in ES-SCLC
5








































